|
|
Volumn 14, Issue 4, 1999, Pages 202-206
|
|
Angiogenesis at the interface between basic and clinical research
a
|
|
Author keywords
Angiogenesis; Chemotherapy; Gene therapy; Inhibitors
|
|
Indexed keywords
2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID;
3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE;
4 DEDIMETHYLAMINOSANCYCLINE;
AE 941;
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
ANTI VEGF;
BMS 275261;
CAI;
CILENGITIDE;
COMBRETASTATIN A4;
ENDOSTATIN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
IM 862;
INTERLEUKIN 12;
MARIMASTAT;
MONOCLONAL ANTIBODY LM 609;
PRINOMASTAT;
SQUALAMINE;
TANOMASTAT;
THALIDOMIDE;
UNCLASSIFIED DRUG;
VATALANIB;
ZK 22584;
ADJUVANT THERAPY;
ANGIOGENESIS;
CANCER;
CELL FUNCTION;
CONFERENCE PAPER;
GENE THERAPY;
TARGET CELL;
|
|
EID: 0033370229
PISSN: 03936155
EISSN: None
Source Type: Journal
DOI: 10.1177/172460089901400402 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (23)
|
